Luitpold Entitled To Some Damages In $120M Contract Dispute
Luitpold Pharmaceuticals Inc. is entitled to damages on claims that Swiss chemical and pharmaceutical conglomerate Ed. Geistlich Soehne AG breached licensing agreements by advertising its dental products in the U.S., a...To view the full article, register now.
Already a subscriber? Click here to view full article